A Q3 2024 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q3 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.6B-5.6% YoY

Gross Profit

$855M54.2% margin

Operating Income

$333M21.1% margin

Net Income

$282M17.9% margin

EPS (Diluted)

$0.97

QoQ Revenue Growth

+0.3%

Cash Flow

Operating Cash Flow

$452M

Free Cash Flow

$360M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$11.0B

Total Liabilities

$5.1B

Stockholders' Equity

$5.9B

Cash & Equivalents

$1.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.7B	-5.6%
Gross Profit	$855M	$658M	+29.9%
Operating Income	$333M	$133M	+150.4%
Net Income	$282M	$111M	+154.1%

Revenue Segments

Life Sciences and Applied Markets

$782M50%

Agilent CrossLab

$411M26%

Diagnostics and Genomics

$385M24%

Geographic Segments

Americas

$626M40%

Asia Pacific

$520M33%

Europe

$432M27%